Pham Quang X 4

What Happened
Pham Quang, a reported 10% owner (trustee of The PVBQ Living Trust), disposed of a total of 11,444 shares of Cadrenal Therapeutics, Inc. (CVKD) common stock in two open-market sales. On 2026-06-22 he sold 9,167 shares at a weighted average price of $3.55 (total ≈ $32,543). On 2026-06-23 he sold 2,277 shares at a weighted average price of $3.20 (total ≈ $7,286). Combined proceeds were about $39,829. These were sales (not purchases), and the transactions were carried out under a Rule 10b5‑1 trading arrangement.

Key Details

• Transaction dates: 2026-06-22 (9,167 shares @ weighted avg $3.55; prices ranged $3.51–$3.62) and 2026-06-23 (2,277 shares @ weighted avg $3.20; prices ranged $3.20–$3.22). (See filing footnotes F2 & F3 for per-price breakdown availability.)
• Total shares sold: 11,444; total proceeds ≈ $39,829.
• Plan: Sales were made pursuant to a Rule 10b5‑1 plan adopted by the reporting person on September 25, 2025 (footnote F1).
• Ownership: Reporting person is a 10% owner and trustee of The PVBQ Living Trust; he has sole voting and dispositive power for the trust (footnote F4).
• Shares owned after transaction: Not specified in the provided filing (the Form 4 did not disclose a post-transaction holding in the summary provided).
• Filing timeliness: Form filed 2026-06-24 for transactions on 6/22–6/23; filing appears timely under Form 4 reporting rules.

Context

• These were prearranged sales under a 10b5‑1 plan, which is a common mechanism insiders use to sell shares on a pre-set schedule and can reduce concerns about trading on non-public information.
• As a 10% owner (not necessarily an officer), this is insider activity but should be interpreted differently than an officer/CEO sale; the filing is factual and does not indicate motivation.